Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
ACS Omega ; 9(32): 34250-34258, 2024 Aug 13.
Artigo em Inglês | MEDLINE | ID: mdl-39157146

RESUMO

Tectonic deformation significantly alters the physical structure of coals, holding great importance to the coal mining industry and coalbed methane. In this study, eight anthracite coal samples with varying degrees of deformation were collected to investigate the effects of tectonic deformation on the pore system and CH4 adsorption of anthracite coals. In addition, low-temperature gas adsorption (N2 and CO2), Raman spectroscopy, and CH4 isothermal experiments were performed. The results revealed that coal samples with higher degrees of deformation exhibited larger ratios of D-band intensity to G-band intensity (I D/I G), indicating increased molecular defects induced by tectonic deformation. As the deformation degree of the coal samples increased, the mesopore volume increased from 0.00044 cm3/g (primary coal) to 0.0019 cm3/g (scaly coal). Conversely, the micropore volume tended to decrease with the increasing deformation degree of the coal samples. Moreover, the impact of deformation degree on the CH4 adsorption capacity of anthracite coals was complex. With the deformation degree increasing, the Langmuir volume initially decreased from 32.0 to 24.55 cm3/g and then rose to 30.14 cm3/g. This complexity arose from the differential effects of tectonic deformation on various pore types, where micropores and mesopores collectively determined the CH4 adsorption capacity of anthracite coals. This study analyzed the influence of tectonic deformation on the pore structure and CH4 adsorption capacity at the molecular level, providing valuable insights for evaluating the in situ CH4 content in anthracite coal seams.

2.
Adv Sci (Weinh) ; 11(36): e2404328, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39052873

RESUMO

Established in 1962, lithium-sulfur (Li-S) batteries boast a longer history than commonly utilized lithium-ion batteries counterparts such as LiCoO2 (LCO) and LiFePO4 (LFP) series, yet they have been slow to achieve commercialization. This delay, significantly impacting loading capacity and cycle life, stems from the long-criticized low conductivity of the cathode and its byproducts, alongside challenges related to the shuttle effect, and volume expansion. Strategies to improve the electrochemical performance of Li-S batteries involve improving the conductivity of the sulfur cathode, employing an adamantane framework as the sulfur host, and incorporating catalysts to promote the transformation of lithium polysulfides (LiPSs). 2D MXene and its derived materials can achieve almost all of the above functions due to their numerous active sites, external groups, and ease of synthesis and modification. This review comprehensively summarizes the functionalization advantages of MXene-based materials in Li-S batteries, including high-speed ionic conduction, structural diversity, shuttle effect inhibition, dendrite suppression, and catalytic activity from fundamental principles to practical applications. The classification of usage methods is also discussed. Finally, leveraging the research progress of MXene, the potential and prospects for its novel application in the Li-S field are proposed.

3.
BMC Anesthesiol ; 14: 12, 2014 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-24588846

RESUMO

BACKGROUND: Shivering is a very common complication in the postanesthesia period. Increasing studies have reported ondansetron may be effective in prevention of postanesthesia shivering (PAS). However, the results remained controversial; hence we conducted a meta-analysis of randomized controlled trials to evaluate the efficacy and safety of ondansetron on the prevention of postanesthesia shivering. METHODS: PubMed and Embase databases were searched to identify the eligible randomized controlled trials assessing the effect of ondansetron on the prevention of PAS. Results were expressed as risk ratios (RRs) with accompanying 95% confidence intervals (CIs). The meta-analysis was performed with fixed-effect model or random-effect model according to the heterogeneity. RESULTS: Six trials including 533 subjects were included. Compared with placebo, ondansetron was associated with a significant reduction of PAS (RR 0.43, 95% CI, 0.27-0.70), without an increased risk of bradycardia (RR 0.37, 95% CI, 0.12-1.15). Compared with meperidine, no difference was observed in the incidence of PAS (RR 0.68, 95% CI, 0.39-1.19) and bradycardia (RR 2.0, 95% CI, 0.38-10.64). CONCLUSIONS: Ondansetron has a preventive effect on PAS without a paralleled side effect of bradycardia.


Assuntos
Ondansetron/administração & dosagem , Ondansetron/efeitos adversos , Complicações Pós-Operatórias/prevenção & controle , Estremecimento/efeitos dos fármacos , Bradicardia/induzido quimicamente , Bradicardia/diagnóstico , Bradicardia/epidemiologia , Humanos , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/epidemiologia , Ensaios Clínicos Controlados Aleatórios como Assunto/métodos , Estremecimento/fisiologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA